Barclays PLC Precision Biosciences Inc Transaction History

Barclays PLC

  • $357 Billion
  • Q4 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024
BUY
$0.29 - $0.45 $5,891 - $9,142
20,316 Added 10.46%
214,524 $78,000
Q1 2023

May 04, 2023
BUY
$0.7 - $1.41 $102,905 - $207,281
147,008 Added 311.46%
194,208 $147,000
Q4 2022

Feb 13, 2023
SELL
$0.97 - $45.0 $2,016 - $93,555
-2,079 Reduced 4.22%
47,200 $56,000
Q3 2022

Nov 03, 2022
SELL
$1.22 - $40.8 $219 - $7,343
-180 Reduced 0.36%
49,279 $64,000
Q2 2022

Aug 12, 2022
BUY
$1.15 - $3.34 $25,501 - $74,064
22,175 Added 81.27%
49,459 $79,000
Q1 2022

May 16, 2022
SELL
$2.96 - $7.76 $142,704 - $374,117
-48,211 Reduced 63.86%
27,284 $84,000
Q4 2021

Feb 14, 2022
BUY
$7.4 - $11.66 $281,518 - $443,581
38,043 Added 101.58%
75,495 $559,000
Q3 2021

Nov 09, 2021
BUY
$9.18 - $14.15 $281,559 - $433,994
30,671 Added 452.31%
37,452 $432,000
Q2 2021

Aug 13, 2021
SELL
$8.07 - $12.52 $265,277 - $411,557
-32,872 Reduced 82.9%
6,781 $86,000
Q1 2021

May 13, 2021
BUY
$8.57 - $15.79 $131,506 - $242,297
15,345 Added 63.13%
39,653 $411,000
Q4 2020

Feb 11, 2021
SELL
$5.98 - $12.47 $122,625 - $255,709
-20,506 Reduced 45.76%
24,308 $202,000
Q3 2020

Nov 12, 2020
BUY
$4.65 - $8.73 $91,363 - $171,527
19,648 Added 78.07%
44,814 $276,000
Q2 2020

Aug 12, 2020
BUY
$4.66 - $8.7 $61,059 - $113,996
13,103 Added 108.62%
25,166 $210,000
Q1 2020

May 13, 2020
SELL
$5.05 - $15.01 $121,427 - $360,915
-24,045 Reduced 66.59%
12,063 $73,000
Q4 2019

Feb 10, 2020
SELL
$6.32 - $19.66 $18,018 - $56,050
-2,851 Reduced 7.32%
36,108 $501,000
Q3 2019

Nov 14, 2019
SELL
$8.03 - $14.82 $10,190 - $18,806
-1,269 Reduced 3.15%
38,959 $327,000
Q2 2019

Aug 14, 2019
BUY
$11.88 - $16.94 $477,908 - $681,462
40,228 New
40,228 $533,000

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $545M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email